Allergies News and Research

Latest Allergies News and Research

Cobalis submits Form of Order with US Bankruptcy Court

Cobalis Corp announced today that the Company's attorneys have submitted a Form of Order consistent with the United States Bankruptcy Court's ruling of April 7, 2010 confirming the debtor's plan of reorganization.

26 May 2010

Research findings on pediatric ILD published online in PED

An insightful and in-depth presentation of the most up-to-date clinical and research findings and historical perspectives on pediatric interstitial lung disease is presented in a special issue published online ahead of print in Pediatric Allergy, Immunology, and Pulmonology, a peer-reviewed journal published by Mary Ann Liebert, Inc.

26 May 2010

QIAGEN acquires rights to 70 molecular food safety tests developed by Institute for Product Quality

QIAGEN today announced that it has entered into an agreement with the Institute for Product Quality (ifp), pursuant to which QIAGEN has acquired all rights to 70 molecular food safety tests developed by the Berlin-based specialized laboratory center for food analysis.

From QIAGEN Manchester Limited 26 May 2010

Lumizyme receives FDA approval for patients with late-onset Pompe disease

The U.S. Food and Drug Administration approved Lumizyme (alglucosidase alfa) for patients ages 8 years and older with late-onset (non-infantile) Pompe disease, a rare genetic disorder.

26 May 2010

Vical receives $4.0M grant to support development of novel vaccine for CMV infection

Vical Incorporated announced today that the company is collaborating with leading pediatric infectious disease researchers Stuart P. Adler, M.D., and Michael A. McVoy, Ph.D., of Virginia Commonwealth University under a five-year, approximately $4.0 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

25 May 2010

Dermatologists recommend broad spectrum sunscreen products to protect against UVA and UVB rays

Sunscreen active ingredients, which are compounds that absorb, scatter or reflect ultraviolet (UV) light, are regulated as over-the-counter (OTC) drugs by the U.S. Food and Drug Administration (FDA).

25 May 2010

New technique designed to analyze individual immune cells may help diagnose food allergies: Study

About 30 percent of Americans believe they have food allergies. However, the actual number is far smaller, closer to 5 percent, according to a recent study commissioned by the National Institute of Allergy and Infectious Diseases. That's due in large part to the unreliability of the skin test that doctors commonly use to test for food allergies.

24 May 2010

Study: Th1 cells play a vital role in pathogenesis of immune-mediated diseases

Current research suggests that T helper-type 1 (Th1) cells, previously thought to mediate autoimmunity, may actual inhibit the development of experimental immune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS), by suppressing Th17 cells.

24 May 2010

New marker may be the significant breakthrough in allergy testing for newborn babies

A simple blood test can now predict whether newborn babies are at high risk of developing allergies as they grow older, thanks to research involving the University of Adelaide.

21 May 2010

Red Cross survey: 68% of Americans involved in some kind of summer emergency

A new Red Cross survey shows that 68 percent of Americans have been involved in some kind of summer emergency, ranging from insect bites, heat stroke and broken bones to more life-threatening situations. One in every four people say they have been in a situation where someone needed CPR.

21 May 2010

Sorrento Therapeutics receives STTR grant to develop antibody therapeutics to combat MRSA

Sorrento Therapeutics, Inc. today announced that it has received an Advanced Technology Small Business Technology Transfer Research grant from the National Institute of Allergy and Infectious Diseases. The peer-reviewed grant was awarded to support the Company's program to generate and develop novel antibody therapeutics and vaccines to combat Staphylococcus aureus infections, including methicillin-resistant S. aureus, by disrupting quorum sensing, a bacterial communication process essential to virulence.

21 May 2010

Ansell Healthcare receives "2010 European Surgical Gloves Product Quality Leadership Award"

Based on its recent research on the surgical drapes, gowns and gloves market, Frost & Sullivan presents Ansell Healthcare Europe (Ansell Healthcare) with the "2010 European Surgical Gloves Product Quality Leadership Award" for its Encore® range of surgical gloves. The range consists of multiple products that are customized to support a wide range of surgical procedures including specialty surgery such as orthopaedics and microsurgery.

21 May 2010

Clinical Infectious Diseases journal examines new scientific advances to curb HIV, TB epidemics

As US policymakers consider scaling back on its historic initiative to fight AIDS around the world and downsizing goals to combat tuberculosis, next-generation treatment and prevention strategies to significantly reduce the spread of HIV/AIDS and tuberculosis are now imminent. New science can dramatically change the trajectory of both deadly epidemics, according to a special new issue of the journal Clinical Infectious Diseases.

21 May 2010

MSCRF awards grants to 42 projects under Maryland Stem Cell Research Act of 2006

The Maryland Stem Cell Research Commission has completed its evaluation of the 141 applications in response to its three official Requests for Applications during the FY 2010 funding cycle. The board of directors of the Maryland Technology Development Corporation reviewed the Commission's recommendations and approved 42 projects totaling $11.7 million in funding through the Maryland Stem Cell Research Fund under the Maryland Stem Cell Research Act of 2006.

21 May 2010

Allergy sufferers can save out-of-pocket costs by visiting urgent care and retail health clinics instead of ER

In this economy, allergy sufferers are looking for relief from more than sneezing, runny noses, and itchy eyes. And, according to a recent study, they can find relief for both their symptoms and their wallets, saving anywhere from $50 to $400 in out-of-pocket costs per visit if they skip the emergency room and head to urgent care and retail health clinics when they are unable to see their primary physician.

20 May 2010

Saint Louis University conducts research to find safe, effective vaccination for dengue

Sponsored by the National Institutes of Health, Saint Louis University's Center for Vaccine Development is conducting research of an investigational vaccine designed to prevent people from contracting dengue, a potentially lethal virus that has rapidly spread around the world.

20 May 2010

NPMA: Cockroach allergens can trigger allergies, asthma attacks

In recognition of National Allergy and Asthma Awareness Month, celebrated each May, the National Pest Management Association is reminding families that cockroach allergens can trigger allergies and asthma attacks. The saliva, droppings and decomposing bodies of cockroaches contain allergen proteins known to trigger allergies and increase the severity of asthma symptoms, especially in children.

20 May 2010

Kansas State University researcher awarded NIH grant to study antibiotic-resistant bacteria

Antibiotic-resistant bacteria are becoming a growing problem around the world, and are a particular worry in hospital-acquired infections.

20 May 2010

Inviragen initiates first clinical trial of DENVax vaccine to protect against dengue fever

Inviragen has announced the initiation of the first clinical trial of its vaccine to protect against dengue fever. The trial, to be conducted at Saint Louis University, is designed to assess the safety of Inviragen's investigational dengue vaccine.

20 May 2010

Alternaria fungus produces more spores with increase in CO2 levels and makes life miserable for allergy, asthma sufferers

A new study of the relationship between carbon dioxide levels and plant growth suggests for the first time that not only do plants grow bigger and produce more pollen when exposed to higher levels of the greenhouse gas, CO2, but the common, allergen-producing fungus Alternaria alternate produces three times more spores when feeding on those enriched plants. The spores disperse on the wind, making allergies and asthma symptoms worse.

19 May 2010

Allergies News and Research

Latest Allergies News and Research

Cobalis submits Form of Order with US Bankruptcy Court

Research findings on pediatric ILD published online in PED

QIAGEN acquires rights to 70 molecular food safety tests developed by Institute for Product Quality

Lumizyme receives FDA approval for patients with late-onset Pompe disease

Vical receives $4.0M grant to support development of novel vaccine for CMV infection

Dermatologists recommend broad spectrum sunscreen products to protect against UVA and UVB rays

New technique designed to analyze individual immune cells may help diagnose food allergies: Study

Study: Th1 cells play a vital role in pathogenesis of immune-mediated diseases

New marker may be the significant breakthrough in allergy testing for newborn babies

Red Cross survey: 68% of Americans involved in some kind of summer emergency

Sorrento Therapeutics receives STTR grant to develop antibody therapeutics to combat MRSA

Ansell Healthcare receives "2010 European Surgical Gloves Product Quality Leadership Award"

Clinical Infectious Diseases journal examines new scientific advances to curb HIV, TB epidemics

MSCRF awards grants to 42 projects under Maryland Stem Cell Research Act of 2006

Allergy sufferers can save out-of-pocket costs by visiting urgent care and retail health clinics instead of ER

Saint Louis University conducts research to find safe, effective vaccination for dengue

NPMA: Cockroach allergens can trigger allergies, asthma attacks

Kansas State University researcher awarded NIH grant to study antibiotic-resistant bacteria

Inviragen initiates first clinical trial of DENVax vaccine to protect against dengue fever

Alternaria fungus produces more spores with increase in CO2 levels and makes life miserable for allergy, asthma sufferers

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Allergies News and Research

Latest Allergies News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in